A Prospective Study of a Mosaic Embryo Transfer
Colorado Center for Reproductive Medicine · NCT04472156
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–45 · Women only
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 250
- US sites recruiting
- 1
- Study start
- October 15, 2020
- Record last updated
- February 29, 2024
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This research is a prospective study in which the purpose is to investigate the clinical outcomes following the transfer of a mosaic embryo (presence of both chromosomally normal and abnormal cells) that has been screened for preimplantation genetic testing (PGT).
Being studied: Transfer of mosaic embryo
Conditions: Infertility
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Women age 18-45 Infertile women who have completed an IVF cycle with PGT at the Colorado Center for Reproductive Medicine (CCRM) that have a mosaic embryo
- Patients can be of any race, culture, sexual orientation or ethnicity
- Patients that are willing to transfer a single embryo
Exclusion Criteria
- Patients that do not meet the clinical requirements for an embryo transfer per clinic standards.
- Patients that desire more than a single embryo transfer.
- Patients that are using a gestational carrier.
- Embryonic mosaic PGT results that include chromosome errors 13, 18, 21
- Patients that did not complete their IVF with PGT cycle at the Colorado Center for Reproductive Medicine.
Recruiting US locations
Colorado Center for Reproductive Medicine
Lone Tree, CO 80124
Site contact: Rachel Makloski, RN · TriggerStudy@colocrm.com
Study contacts (from the official record)
- Rachel Makloski, RN · 303-788-8300 · rmakloski@colocrm.com
Similar studies in Colorado
All women’s health studies in Colorado →- RecruitingHealthy volunteersPhase 1
Use of Pulsatile Intravenous FSH to Mitigate Reprometabolic Syndrome
University of Colorado, Denver
- Location
- Aurora, CO
- Eligibility basics
- Ages 19–37 · Women only
- RecruitingPhase 3
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Sumitomo Pharma Switzerland GmbH
- Location
- Aurora, CO + 101 other US sites
- Eligibility basics
- Ages 18–50 · Women only
- RecruitingHealthy volunteersPhase 2
Long Term Evaluation of Scapular-inserted Contraceptive Implants
Yale University
- Location
- Aurora, CO + 1 other US site
- Eligibility basics
- Ages 18–45 · Women only
- RecruitingHealthy volunteersPhase 4
Cyclic vs. Constant Estradiol: Regimens' Effects on Brain Health
University of Colorado, Denver
- Location
- Aurora, CO
- Eligibility basics
- Ages 38–60 · Women only